Homocysteine, Cause or Consequence?

International Journal of Cardiology

Volumn 129, Issue 2, 2008, Pages 276-277

  Martin Herrero, Francisco ^a   Jiménez Candil, Javier ^a   Martín Moreiras, Javier ^a   Pabón, Pedro ^a   Cruz González, Ignacio ^a   Martín García, Ana ^a   León, Victor ^a   Martín Luengo, Cándido ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Acute coronary syndrome; Homocysteine lowering treatment; Risk stratificacion

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; TROPONIN I;

ACUTE CORONARY SYNDROME; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; DISEASE MARKER; HYPERHOMOCYSTEINEMIA; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 50349094851     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.091     Document Type: Article

References (10)

1. Celik T., Iyisoy A., Bugan B., Yuksel Cagdas U., Isik E., et al. Does homocysteine-lowering treatment improve cardiovascular outcomes in patients with acute coronary syndromes? What we have learned from clinical trials?. Int J Cardiol 129 (2008) 274-275
2. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
3. Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
4. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
5. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
6. Loscalzo J. Homocystiene trials. Clear outcomes for complex reasons. N Engl J Med 354 (2006) 1629-1632
7. Whincup P.H., Refsum H., Perry I.J., et al. Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 82 4 (1999) 448-454
8. Zylberstein D.E., Bengtsson C., Björkelund C., et al. Serum homocysteine in relation to mortality and morbidity from coronary heart desease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 109 5 (2004) 601-606
9. Stubbs P.J., Al-Obaidi M.K., Conroy R.M., et al. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 102 6 (2000) 605-610
10. Martín-Herrero F., Martín-Moreiras J., Pabón P., et al. Homocysteine and outcome in young patients with acute coronary sindromes. Int J Cardiol 118 2 (2007) 183-188